首页|基于决策树分类方式对北京地区2019-2021年871例乳腺癌患者住院费用研究

基于决策树分类方式对北京地区2019-2021年871例乳腺癌患者住院费用研究

扫码查看
目的 利用决策树分类方式分析北京地区3年内871例乳腺癌患者的住院费用,为管理部门决策奠定理论基础.方法 收集2019年1月1日-2021年12月31日北京地区871例乳腺癌住院患者的病案首页,分析不同年份其住院费用构成情况,并通过决策树分类模型将所有患者进行疾病诊断相关分类(DRGs),采用绝对值及相对权重法测算所有乳腺癌患者的住院费用标准.结果 乳腺癌患者2019-2021年住院总费用从高至低分别为2020年3 523 965.98元<2019年3 763 289.85元<2021年3 924 283.54元;各个年份均为药品费用所占的构成比最大,护理康复费呈逐年上升趋势;多重线性回归分析显示治疗方式、医疗付款方式及转归情况对住院费用影响最大,P<0.05;经交叉验证方法对验证所构建出的决策树从而得到12个DRGs组合,具有较高的组内同质性;各分组费用超标例数均在10%~12%左右,且DRGs中9组的病种权重最高(1.92),DRGs中6组的病种权重最低(0.42).结论 药品费用是目前乳腺癌患者住院期间的最大经济负担,同时不同的治疗方式、医疗付款方式及转归情况是目前临床中影响乳腺癌患者住院费用最大的几类因素;决策树DRGs组合对住院乳腺癌患者具有较高的组内同质性,通过DRGs分组进行医疗资源合理配置具有重要指导意义.
Research on Hospitalization Expenses of 871 Breast Cancer Patients in Beijing from 2019 to 2021 Based on Decision Tree Classification Method
Objectives This study aims to analyze the hospitalization costs of 871 breast cancer patients in Beijing within 3 years by decision tree classification method,laying a theoretical foundation for management department decision-making.Methods The front pages of medical records of 871 inpatients with breast cancer in Beijing from January 1,2019 to December 31,2021 were collected to analyze the composition of hospitalization expenses in different years.All patients were classified into diagnosis-related categories(DRGs)by the decision tree classification model.Absolute value and relative weight methods were used to measure the hospitalization expenses of all breast cancer patients.Results The total hospitalization expenses for breast cancer patients from 2019 to 2021 from high to low were:3,523,965.98 yuan(2020)<3,763,289.85 yuan(2019)<3,924,283.54 yuan(2021).In every year,drug expenses accounted for the largest proportion,and nursing and rehabilitation expenses showed an increasing trend year by year.Multiple linear regression analysis showed that treatment methods,medical payment methods,and outcomes have the greatest impact on hospitalization costs,P<0.05.After the cross-validation method,the decision tree constructed was verified to obtain 12 DRGs combinations,which had high intra-group homogeneity.The number of cases with excessive expenses in each group was around 10%to 12%.Among the DRGs,group 9 had the highest disease weight(1.92),and group 6 among the DRGs had the lowest weight(0.42).Conclusions Drug cost is the biggest economic burden of breast cancer patients during hospitalization.Meanwhile,different treatment methods,medical payment methods,and transfer conditions are the biggest factors affecting the hospitalization cost of breast cancer patients.The DRGs combination of decision tree has high intra-group homogeneity for inpatients with breast cancer,and it has important guiding significance for rational allocation of medical resources after grouping them by DRGs.

Decision tree classificationBreast cancer patientsHospital expensesDecision-making research

王宇、曹彤欣、孟怡然

展开 >

首都医科大学附属北京积水潭医院普外科,北京市,100000

决策树分类 乳腺癌患者 住院费用 决策研究

北京市卫生科技发展专项

2016-82

2024

中国病案
中国医院协会

中国病案

CSTPCD
影响因子:1.197
ISSN:1672-2566
年,卷(期):2024.25(3)
  • 14